Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2010 May 13:2010:bcr11.2009.2419.
doi: 10.1136/bcr.11.2009.2419.

X-linked adrenoleukodystrophy presenting as Addison's disease

Affiliations
Case Reports

X-linked adrenoleukodystrophy presenting as Addison's disease

Bernhard Kaspar Morell et al. BMJ Case Rep. .

Abstract

We report the case of a young man with a history of attention deficit/hyperactivity disorder and mild cognitive impairment who presented with chronic fatigue, anorexia and progressive darkening of the skin. On laboratory testing, severely depressed concentrations of morning cortisol, along with highly elevated values of adrenocorticotropic hormone (ACTH) revealed primary adrenal insufficiency as the primary cause of the patient's symptomatology. Imaging of the brain showed altered signal intensities in the parieto-occipital regions of the brain. The demonstration of increased very long chain fatty acids (VLCFA) established the diagnosis of adolescent X-linked adrenoleukodystrophy (X-ALD). Presenting at an advanced yet slowly progressive stage the patient was not a suitable candidate for haematopoietic stem cell transplantation (HSCT), and treatment focused on hormone replacement therapy, family counselling and supportive care. On follow-up visits within the following year, fatigue had diminished and there was no evidence of progressive neurological deficits. However, exacerbation of the psychiatric symptomatology resulted in admittance to a psychiatric ward.

PubMed Disclaimer

Figures

Figure 1
Figure 1
T2 weighted images of the brain showing characteristic periventricular hyperintensities in the parieto-occipital region of the brain (A) and atrophic changes of the splenium corpori callosi (B), yet no active inflammatory changes are appreciated following the application of contrast material.

Similar articles

Cited by

References

    1. Moser HW, Mahmoud A, Raymond GV. X-linked adrenoleukodystrophy. Nature Clinical Practice Neurology 2007; 3: 140–51 - PubMed
    1. Moser HW, Moser AB, Smith KD, et al. Adrenoleukodystrophy: phenotypic variability and implications for therapy. J Inherit Metab Dis 1992; 15: 645–64 - PubMed
    1. X-linked Adrenoleukodystrophy Database (www.x-ald.nl)
    1. Asheuer M, Bieche I, Laurendeau I, et al. Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy. Human Molecular Genetics 2005; 14: 1293–303 - PubMed
    1. Moser HW. Therapy of X-linked adrenoleukodystrophy. NeuroRx 2006; 3: 246–53 - PMC - PubMed

Publication types